Article
Molecular and Cellular Mechanisms of Myelodysplastic Syndrome: Implications on Targeted Therapy
24 Mar 2016
Abstract excerpt
Myelodysplastic syndrome (MDS) is a group of heterogeneous clonal hematopoietic stem cell disorders characterized by cytopenia, ineffective hematopoiesis, and progression to secondary acute myeloid leukemia in high-risk cases. Conventional prognostication relies on clinicopathological parameters supplemented by cytogenetic information. However, recent studies have shown that genetic aberrations also have critical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
